Jue‐Sheng Ong

ORCID: 0000-0002-6062-710X · 69 papers in corpus
preprint 2023
·doi:10.1158/1055-9965.c.6695948.v2

AbstractBackground:Although folate intake has not been associated with an increased risk of ovarian cancer overall, studies of other cancer types have suggested that high folate intake may promote carcinogenesis in precancerous lesions. Wom…

preprint 2023
·doi:10.1158/1055-9965.c.6695948

AbstractBackground:Although folate intake has not been associated with an increased risk of ovarian cancer overall, studies of other cancer types have suggested that high folate intake may promote carcinogenesis in precancerous lesions. Wom…

preprint 2023
·doi:10.1158/1055-9965.c.6695948.v1

AbstractBackground:Although folate intake has not been associated with an increased risk of ovarian cancer overall, studies of other cancer types have suggested that high folate intake may promote carcinogenesis in precancerous lesions. Wom…

other 2023
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology ·doi:10.1158/1055-9965.EPI-23-0121

BACKGROUND: Although folate intake has not been associated with an increased risk of ovarian cancer overall, studies of other cancer types have suggested that high folate intake may promote carcinogenesis in precancerous lesions. Women with…

preprint 2023
·doi:10.1158/1055-9965.23516099.v1

Supplementary Figure 1 shows a flowchart of exclusions to obtain the study population, with the number of cases and controls eligible for the analysis.

preprint 2023
·doi:10.1158/1055-9965.23516099

Supplementary Figure 1 shows a flowchart of exclusions to obtain the study population, with the number of cases and controls eligible for the analysis.

preprint 2023
·doi:10.1158/1055-9965.23814285.v1

Supplementary Figure 1 shows a flowchart of exclusions to obtain the study population, with the number of cases and controls eligible for the analysis.

preprint 2023
·doi:10.1158/1055-9965.23814285

Supplementary Figure 1 shows a flowchart of exclusions to obtain the study population, with the number of cases and controls eligible for the analysis.

preprint 2023
·doi:10.1158/1055-9965.23516096

Supplementary Figure 2 shows two forest plots depicting the association between (A) dietary folate intake and (B) supplemental folate intake and ovarian cancer for women with endometriosis, stratified by potential effect modifiers

preprint 2023
·doi:10.1158/1055-9965.23814282

Supplementary Figure 2 shows two forest plots depicting the association between (A) dietary folate intake and (B) supplemental folate intake and ovarian cancer for women with endometriosis, stratified by potential effect modifiers

preprint 2023
·doi:10.1158/1055-9965.23516096.v1

Supplementary Figure 2 shows two forest plots depicting the association between (A) dietary folate intake and (B) supplemental folate intake and ovarian cancer for women with endometriosis, stratified by potential effect modifiers

preprint 2023
·doi:10.1158/1055-9965.23814282.v1

Supplementary Figure 2 shows two forest plots depicting the association between (A) dietary folate intake and (B) supplemental folate intake and ovarian cancer for women with endometriosis, stratified by potential effect modifiers

preprint 2023
·doi:10.1158/1055-9965.23516093.v1

Supplementary Figure 3 shows scatter plots with the genetic association with folate on the x-axis andthe genetic association with ovarian cancer on the y-axis, for (A) women with and (B) without endometriosis. The regression line for the in…

preprint 2023
·doi:10.1158/1055-9965.23814279

Supplementary Figure 3 shows scatter plots with the genetic association with folate on the x-axis and the genetic association with ovarian cancer on the y-axis, for (A) women with and (B) without endometriosis. The regression line for the i…

preprint 2023
·doi:10.1158/1055-9965.23814279.v1

Supplementary Figure 3 shows scatter plots with the genetic association with folate on the x-axis and the genetic association with ovarian cancer on the y-axis, for (A) women with and (B) without endometriosis. The regression line for the i…

preprint 2023
·doi:10.1158/1055-9965.23516093

Supplementary Figure 3 shows scatter plots with the genetic association with folate on the x-axis andthe genetic association with ovarian cancer on the y-axis, for (A) women with and (B) without endometriosis. The regression line for the in…

supplementary-materials 2023
·doi:10.1158/1055-9965.23516090

Supplementary Table 1 shows the range of folate intake included in each tertile, by OCAC study site.

supplementary-materials 2023
·doi:10.1158/1055-9965.23814276.v1

Supplementary Table 1 shows the range of folate intake included in each tertile, by OCAC study site.

supplementary-materials 2023
·doi:10.1158/1055-9965.23814276

Supplementary Table 1 shows the range of folate intake included in each tertile, by OCAC study site.

supplementary-materials 2023
·doi:10.1158/1055-9965.23516090.v1

Supplementary Table 1 shows the range of folate intake included in each tertile, by OCAC study site.

supplementary-materials 2023
·doi:10.1158/1055-9965.23814273.v1

Supplementary Table 2 shows the single nucleotide polymorphisms (SNPs) used as instruments for folate level in the Mendelian randomization analysis.

supplementary-materials 2023
·doi:10.1158/1055-9965.23814273

Supplementary Table 2 shows the single nucleotide polymorphisms (SNPs) used as instruments for folate level in the Mendelian randomization analysis.

supplementary-materials 2023
·doi:10.1158/1055-9965.23516087.v1

Supplementary Table 2 shows the single nucleotide polymorphisms (SNPs) used as instruments for folate level in the Mendelian randomization analysis.

supplementary-materials 2023
·doi:10.1158/1055-9965.23516087

Supplementary Table 2 shows the single nucleotide polymorphisms (SNPs) used as instruments for folate level in the Mendelian randomization analysis.

supplementary-materials 2023
·doi:10.1158/1055-9965.23516084

Supplementary Table 3 shows the associations between folate intake (dietary, supplemental, total) and ovarian cancer by endometriosis status, and by histological subtype (endometrioid/clear cell cancers and high grade serous cancers).